News

Valeant completes Sanitas Group acquisition

BY Allison Cerra

MISSISSAUGA, Ontario — Canada-based drug maker Valeant Pharmaceuticals International has acquired a Kaunas, Lithuania-based specialty pharmaceutical company.

Valeant said it completed its acquisition of Sanitas Group, which operates in Central and Eastern Europe and Russia markets.

The deal, which initially was announced by Valeant in May, was valued at EUR314 million (about $450 million) in cash.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

News

Study: Diabetes, hypertension patients at risk of developing glaucoma

BY Allison Cerra

NEW YORK — Americans that suffer from diabetes and/or hypertension are at risk of developing a common type of glaucoma, according to researchers at the University of Michigan Kellogg Eye Center.

The study, led by Kellogg glaucoma specialist Joshua Stein and funded by the National Eye Institute, reviewed billing records of more than 2 million people that were enrolled in a managed care network. These subjects visited an eye care provider one or more times between 2001 and 2007. Based on the data collected, Stein and his fellow researchers discovered that diabetics had a 35% increased risk of developing open-angle glaucoma, while hypertension patients had a 17% increased risk of developing OAG. For people with both diabetes and hypertension, however, they faced an increased risk of developing OAG of almost 50%.

"Patients who have diabetes and hypertension are already known to be at elevated risk for eye conditions like diabetic retinopathy, a condition that harms the blood vessels in the retina," Stein said. "This study and others suggest that, for these patients, an increased likelihood of glaucoma is also a concern. This study reinforces the importance of regular eye examinations for patients at increased risk of glaucoma, including those with diabetes and hypertension."

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

News

Career pharmacist Edward Spearbeck passes at 78

BY Michael Johnsen

ARLINGTON, Va. — Pharmacist Edward Spearbeck, 78, passed on Aug. 14, according to a report in the Washington Post published Thursday.

Spearbeck, a 40-year veteran of Drug Fair, started working as a pharmacist in 1948. He retired in 1987 as director of professional services. He also served as a U.S. Army Hospital Pharmacist for two years during the Korean War, and was the director of professional services at Retired Persons Services of AARP from 1988 until 2003. Spearbeck was a member of The Virginia Pharmaceutical Association and served on the association’s executive board for two decades. Spearbeck also held all elected offices of the Potomac Pharmacists Association, and was an active member of the American Pharmaceutical Association, AMCP, ASCP and the National Association of Retail Druggists.

According to the report, Spearbeck also was affiliated with the Virginia Regional Medical Planning Board, the Virginia Professional Standards Review Organization, The NAPB task force on Innovative Pharmacy, The DEA Pharmacy Committee, The NDC/UPC AdHoc Development and Implementation Committee and NACDS Pharmacy Affairs Committee as past chairman and member.

He was preceded in death by Loraine Cox Spearbeck, his wife of more than 54 years, who died Jan. 19. He is survived his two sons, Ken Spearbeck of Arlington, Va., and Ned Spearbeck, wife Jane and granddaughter Janice Spearbeck of La Plata, Md.

Visitation will be held at Murphy Funeral Home in Arlington, Va. on Aug. 21 from 4 p.m. until 7 p.m. Mass of Christian burial will be offered at St. Ann Catholic Church, also in Arlington, on Aug. at 10 a.m.

For the full report, click here.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES